| Literature DB >> 31198899 |
Abstract
Aim: To assess the central corneal thickness (CCT) and endothelial cell loss after manual small-incision cataract surgery and phacoemulsification in patients with white cataract. Material and methods: This is a comparative, prospective, non-randomized study on 42 patients with white cataract, who underwent cataract surgery. The patients were divided into manual small-incision cataract surgery (21 eyes, MSICS group) and phacoemulsification cataract surgery group (21 eyes, phaco group). The endothelial cell density (ECD), central cornea thickness (CCT), and corrected distance visual acuity (CDVA) were evaluated at 1 day, 1 week, 4 weeks, and 3 months postoperatively. The results of 20 cases of nuclear sclerosis grade II-III (LOCS III) who underwent phacoemulsification by the same surgeon were also compared. Propensity scoring was used to adjust for confounding by selection bias.Entities:
Keywords: central corneal thickness; endothelial cell loss; manual small incision cataract surgery; phacoemulsification; white cataract
Mesh:
Year: 2019 PMID: 31198899 PMCID: PMC6531777
Source DB: PubMed Journal: Rom J Ophthalmol ISSN: 2457-4325
Patient baseline characteristics
| Patient characteristics | MSICS (n= 21) | MSICS (n= 21) | |||
| n | % | n | % | p-value | |
| Gender | |||||
| Male | 7 | 44.6 | 8 | 53.3 | |
| Female | 14 | 48.2 | 13 | 51.8 | 0.747 |
| Age (year) | |||||
| Mean ± sd | 62.3 ±4.0 | 68.6 ±1.9 | 0.083 | ||
| Pre-op VA <6/ 60 | 21 | 100 | 21 | 100 | |
| Laterality (R) | 11 | 47.8 | 12 | 52.2 | 1.000 |
| Duration of Sx (min) Mean+-SD | 13.2 ±0.6 | 13.2 ±0.6 | 0.086 | ||
| Nuclear opacity | |||||
| NS ≤ 3+ | 16 | 72.6 | 13 | 61.9 | 0.202 |
| NS 4+ | 5 | 23.8 | 8 | 38.1 |
Comparative clinical outcomes of phacoemulsification in normal cataract and white cataract by the same surgeon
| Phaco I (N=20) | Phaco (N=21) | p-value | |
| Mean age | 68.4 ± 2.24 | 68.6 ± 1.93 | 0.94 |
| Female sex, n (%) | 7 (35.0) | 13 (61.9) | 0.085 |
| Operation time (Min) | 9.9 ± 0.36 | 16.5 ± 12.3 | 0.009 |
| Mean US power | 24.5 ± 0.94 | 30.1 ± 1.5 | 0.004 |
| Mean APT(s) ± SD | 50.4 ± 3.35 | 95.9 ± 13.6 | 0.006 |
| Mean EPT(s) ± SD | 12.2 ± 1.1 | 37.7 ± 5.7 | 0.0007 |
| CCT Increase (µ) | 67.4 ± 72.7 | 138.0 ± 103.1 | 0.018 |
| Cell loss (%) | 8.4 ± 8.1 | 15.8 ± 8.4 | 0.024 |
| Postop VA > 6/ 18 | 19 (95%) | 19 (90.5%) | 1.00 |
Clinical outcomes
| Clinical outcomes | MSICS (n = 21) | Phaco (n = 21) | |||
| X | SD | X | SD | p-value | |
| CCT | |||||
| PRE | 531.6 | 40.1 | 544.2 | 45.0 | 0.342 |
| 1 D | 603.0 | 77.6 | 682.2 | 104.3 | 0.008 |
| 0.008 | 537.5 | 46.4 | 562.5 | 42.0 | 0.076 |
| 1 mo | 528.9 | 41.2 | 542.9 | 44.3 | 0.299 |
| CELL | |||||
| PRE | |||||
| 1 mo | 2540.2 | 218.4 | 2486.6 | 218.5 | 0.495 |
| 3 mo | 2314.9 | 215.3 | 2214.1 | 347.6 | 0.265 |
| 2239.4 | 232.5 | 2058.3 | 315.0 | 0.060 | |
| Cell loss (%) | |||||
| 11.8 | 6.4 | 15.8 | 8.4 | 0.111 | |
Postoperative visual acuity
| Postoperative visual acuity | MSICS (n = 21) | Phaco (n = 21) | |||
| n | % | n | % | p-value | |
| Post VA 1 week | |||||
| < 6/ 60 | 1 | 4.8 | 0 | 0 | 0.454 |
| 6/ 60-6/ 18 | 5 | 23.8 | 3 | 14.3 | |
| > 6/ 18 | 15 | 71.4 | 18 | 85.7 | |
| Post VA 4 week | |||||
| < 6/ 60 | 1 | 4.8 | 0 | 0 | 1.000 |
| 1.000 | 1 | 4.8 | 2 | 9.5 | |
| > 6/ 18 | 19 | 90.5 | 19 | 90.5 | |